| Product Code: ETC066703 | Publication Date: Jun 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India Infectious Disease Point-of-care Testing Market was estimated at USD 1154 Million in 2025 and is projected to reach USD 1652 Million by 2032, growing at a CAGR of 5.3% from 2026 to 2032. This positive trajectory is driven by the escalating incidence of infectious diseases across the nation, coupled with increased government support for diagnostic initiatives. Furthermore, rapid technological advancements in testing methodologies and the growing need for swift, reliable results in healthcare settings are significantly bolstering the market.
This graph highlights how the India Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.4% | Increasing industrial infrastructure investments |
| 2022 | 9.2% | Growing urbanization and commercial development |
| 2023 | 7.6% | Government infrastructure modernization initiatives |
| 2024 | 7.6% | Growing urbanization and commercial development |
| 2025 | 7.5% | Government infrastructure modernization initiatives |
| 2026 | 7.9% | Growing urbanization and commercial development |
| 2027 | 6.2% | Expansion of commercial construction activities |
| 2028 | 6.0% | Expansion of commercial construction activities |
| 2029 | 6.3% | Government infrastructure modernization initiatives |
| 2030 | 6.6% | Expansion of commercial construction activities |
| 2031 | 6.0% | Growing renewable energy integration projects |
| 2032 | 6.5% | Government infrastructure modernization initiatives |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Indian landscape for infectious disease point-of-care testing is evolving rapidly. With the country's diverse epidemiological profile, the demand for efficient and accessible diagnostic tools has never been greater. A surge in the prevalence of diseases such as HIV, malaria, and dengue fever necessitates rapid testing solutions that can enhance patient outcomes and enable timely intervention.
Government initiatives aimed at improving healthcare infrastructure and increasing public awareness about infectious diseases are fueling market growth. Furthermore, the rise of rapid test kits and automation in diagnostics makes point-of-care testing increasingly appealing to healthcare professionals across various settings.
Despite the promising growth outlook, several constraints hinder the India Infectious Disease Point-of-care Testing Market. Primarily, the high cost associated with advanced testing devices poses a significant barrier to widespread adoption, particularly in rural and underserved areas. Furthermore, a notable lack of awareness regarding effective infection control practices among health practitioners may undermine the efficacy of point-of-care testing initiatives. Addressing these issues will be crucial for harnessing the full potential of the market.
Current trends within the India Infectious Disease Point-of-care Testing Market highlight a shift towards more sophisticated diagnostic technologies. The integration of optical and electrochemical immunosensors utilizing fluorescence technology is revolutionizing point-of-care testing applications. Moreover, the increasing preference for decentralized testing is reshaping healthcare delivery, providing patients with immediate results and enhancing treatment pathways.
The future of the India Infectious Disease Point-of-care Testing Market presents several lucrative opportunities for growth and investment. Innovations in diagnostic technologies, coupled with the ongoing push for healthcare accessibility, create fertile ground for new entrants and established players alike. Additionally, collaborations between public and private sectors can foster advancements in testing capabilities and affordability, further propelling market expansion.
The Indian government has launched various initiatives aimed at improving the landscape of infectious disease diagnosis and treatment. Increased public spending on healthcare infrastructure, initiatives focusing on public health awareness, and supportive policies for research and development are pivotal in enhancing the efficacy of point-of-care testing. These efforts are crucial in combating the high burden of infectious diseases across the nation.
Looking ahead to the period from 2026 to 2032, the India Infectious Disease Point-of-care Testing Market is poised for substantial transformation. Continuous advancements in diagnostic technology and a greater emphasis on personalized medicine will likely redefine patient care approaches. As healthcare systems evolve, a growing focus on rapid, point-of-care diagnostics will be essential in addressing the mounting challenges posed by infectious diseases in India.
Recent developments in the India Infectious Disease Point-of-care Testing Market indicate a shift towards innovative solutions aimed at enhancing diagnostic accuracy and speed. Numerous firms are dedicating resources to research and development, aiming to introduce advanced testing methodologies. This has led to an uptick in collaborations and partnerships that focus on developing user-friendly, cost-effective solutions tailored to the Indian healthcare context.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Infectious Disease Point-of-care Testing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 India Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 India Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 India Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 India Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 India Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Infectious Disease Point-of-care Testing Market Trends |
6 India Infectious Disease Point-of-care Testing Market, By Types |
6.1 India Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 India Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 India Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 India Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 India Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 India Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 India Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 India Infectious Disease Point-of-care Testing Market Key Performance Indicators |
9 India Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 India Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 India Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 India Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 India Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 India Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 India Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here